BRIEF published on 01/29/2026 at 21:01, 1 month 27 days ago Le groupe Vanguard annonce la divulgation de ses intérêts dans Spire Healthcare. Spire Healthcare Code De Prise De Contrôle Le Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières
PRESS RELEASE published on 01/29/2026 at 21:01, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.07% stake in JTC plc as of 28 January 2026. Form 8.3 filing under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake JTC Plc
BRIEF published on 01/29/2026 at 20:59, 1 month 27 days ago The Vanguard Group Discloses Position in Dauch Corporation Disclosure Takeover Code Vanguard Group Securities Interests Dauch Corporation
BRIEF published on 01/29/2026 at 20:59, 1 month 27 days ago Le groupe Vanguard révèle sa participation dans Dauch Corporation Groupe Vanguard Code De Prise De Contrôle Divulgation Intérêts En Valeurs Mobilières Dauch Corporation
PRESS RELEASE published on 01/29/2026 at 20:59, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses ownership of 1.24% stake in Bluefield Solar Income Fund Limited. Sale of 291,121 securities at 0.71 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Securities Sale Bluefield Solar Income Fund
BRIEF published on 01/29/2026 at 20:58, 1 month 27 days ago The Vanguard Group Discloses Position in Dowlais Group plc Takeover Code Vanguard Group Shareholding Stock Disclosure Dowlais Group
BRIEF published on 01/29/2026 at 20:58, 1 month 27 days ago Le groupe Vanguard révèle sa participation dans Dowlais Group plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Informations Boursières Groupe Dowlais
PRESS RELEASE published on 01/29/2026 at 20:57, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. files Form 8.3 disclosure for Beazley plc, revealing 5.02% stake in 5p ordinary shares on 28 Jan 2026 Form 8.3 Disclosure The Vanguard Group 5p Ordinary Shares Beazley Plc
BRIEF published on 01/29/2026 at 20:56, 1 month 27 days ago The Vanguard Group Discloses Stake in Auction Technology Group Takeover Code Securities Disclosure Vanguard Group Stake Sale Auction Technology
BRIEF published on 01/29/2026 at 20:56, 1 month 27 days ago Le groupe Vanguard révèle sa participation dans Auction Technology Group Groupe Vanguard Code De Prise De Contrôle Vente De Parts Technologie Des Enchères Information Sur Les Valeurs Mobilières
Published on 03/26/2026 at 16:20, 3 hours 58 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 7 hours 18 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 7 hours 18 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 7 hours 19 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 19:20, 57 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 1 hour 8 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 1 hour 8 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 2 hours 1 minute ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 2 hours 1 minute ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 2 hours 18 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 2 hours 18 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité